NCT04834492

Brief Summary

Total hip arthroplasty (THA) performed for developmental dysplasia of the hip (DDH) is a technically difficult procedure with a high complication rate, especially in the presence of completely dislocated hips. This study aimed to evaluate the results of at least 10 years of follow-up results of cementless, ceramic-on-ceramic (CoC) total hip arthroplasty performed with transverse subtrochanteric osteotomy in Crowe type 4 hips.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

7 months

First QC Date

April 4, 2021

Last Update Submit

April 4, 2021

Conditions

Keywords

Developmental dysplasia of the hip, total hip arthroplasty, transverse subtrochanteric shortening osteotomy, ceramic on ceramic, cementless.

Outcome Measures

Primary Outcomes (1)

  • Clinical results

    Haris Hip Score

    minimum 10 year follow-up

Interventions

Total hip arthroplasty in Crowe type 4 developmental dysplasia of the hip.

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Crowe type 4 developmental dysplasia of the hip patient

You may qualify if:

  • Crowe type 4 developmental dysplasia of the hip

You may not qualify if:

  • Primary Coxarthrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private Ortopedia Hospital

Adana, Adana, 01130, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Developmental Dysplasia of the Hip

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

Hip DislocationJoint DislocationsJoint DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 4, 2021

First Posted

April 8, 2021

Study Start

July 15, 2020

Primary Completion

February 10, 2021

Study Completion

March 30, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations